Revised estimates of types and duration of long COVID symptoms based on claims records from 245 million US patients
En palabras de los autores
COVID-19 has been reported to cause multisystem effects lasting years [Z. Al-Aly, E. Topol, Science 383, 830-832 (2024)]. These findings are primarily based on cohort studies comparing test-positive COVID-19 patients to controls without known COVID-19 infection, tested or untested [M. Cai, Y. Xie, E. J. Topol, Z. Al-Aly, Nat. Med. 30, 1564-1573 (2024)]. However, such comparisons can be biased by the reasons people were tested. Using 14.4 billion insurance claims from 244.7 million US patients, we find that most long-term effects attributed to COVID-19 by unrestricted control designs likely reflect bias due to selective testing of individuals with non-COVID conditions, causing long-term effects of those conditions to be misattributed to COVID-19. We removed this bias by analyzing only tested individuals, comparing test-positive to test-negative patients. Across 614 clinical outcomes followed over 2 y, the test-based design resulted in 83.5% fewer symptoms being attributable to COVID-19 between 30 to 119 d after infection (43 attributable symptoms vs. 262 for the unrestricted control design), a 98.2% reduction at 120 to 359 d (5 vs. 286), and a 100% reduction at 360 to 719 d (0 vs. 369). The unrestricted control design also attributed unrelated outcomes (e.g., firearm injuries) to COVID-19 at a high rate, whereas the testing-based design did not. The test-based control design may modestly underestimate some effects. This study does not indicate that symptoms beyond one year are not genuine but that their attributability to COVID-19 is uncertain.
En palabras simples Resumen con IA
Los autores analizaron 14.4 mil millones de reclamaciones de seguros de 244.7 millones de pacientes estadounidenses. Encontraron que diseños de estudio comunes que comparan pacientes COVID-positivos con controles no probados probablemente sobrecuentan los síntomas de COVID prolongado. Cuando compararon solo pacientes probados, hubo 83.5% menos síntomas vinculados al COVID-19 a los 30-119 días, y 100% menos a los 360-719 días. El método más estricto puede subestimar ligeramente algunos efectos. Los autores no afirman que los síntomas más allá de un año sean falsos, solo que su vínculo con el COVID-19 es incierto.
Escrito por Kimi K2.5 usando solo el abstract de arriba. Jev verificó que cada oración esté respaldada por las oraciones del abstract que cita y eliminó las que no. Pasá el cursor por una oración para ver de dónde sale.
Apareció: jueves, 29 de octubre. Proceedings of the National Academy of Sciences. Revista con revisión por pares.